mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

Gül A. İŞBİLEN

Author Profile
Faculty of Pharmacy, Ankara University, Ankara, Turkey
1
Publications
1
Years Active
4
Collaborators
42
Citations

Publications by Gül A. İŞBİLEN

1 publication found • Active 2017-2017

2017

1 publication

In Vitro Aldose Reductase Inhibitory Activity of Some 2,4-Thiazolidinedione Derivatives

with Meltem CEYLAN-ÜNLÜSOY, Mutlu SARIKAYA, Oya BOZDAĞ-DÜNDAR, Net DAŞ-EVCİMEN
4/1/2017

Aldose reductase (ALR2; AR; EC 1.1.1.21) is the first enzyme of the polyol pathway, which reduces glucose to sorbitol, in the presence of NADPH. The pathway is completed by sorbitol dehydrogenase, which catalyzes the NAD-linked oxidation of sorbitol to fructose. Synthesis and accumulation of sorbitol in cells due to increased aldose reductase activity is one of the main causes of diabetic complications. The aim of our study is to determine the potential inhibitory effect of some 2, 4-TZD derivatives on aldose reductase enzyme activity. Aldose reductase enzyme is isolated from bovine lenses and the activity of the enzyme is determined by spectrophotometric method. In our study 13 thiazolidinedione (TZD) derivatives which are containing benzyl and phenacyl groups were studied. Maximum inhibitory activity was found with 2,4- TZD-N-unsubstituted compound (86 %).  Compound 13, unsubstituted compound which was showed the maximum inhibitory activity, will be the key formula of our future studies.

Author Statistics
Total Publications:1
Years Active:1
First Publication:2017
Latest Publication:2017
Collaborators:4
Citations:42
Whatsapp